Fibrin associated large B-cell lymphoma accidentally identified in a breast implant capsule: a molecular report of a rare entity
Pathologica · 2024
DOI: 10.32074/1591-951x-944 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathologica, 2024. Verfasst von Cristian Scatena und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Breast Implants, Fibrin, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Breast implant-associated (BIA) lymphoma is a rare malignancy, typically originating from T-cells; however, few cases of diffuse large B-cell lymphoma (LBCL) have been recently described. These cases share major features: Epstein-Barr virus positivity and a favorable prognosis with surgical intervention alone, hinting at a potential link to fibrin-associated LBCL (FA-LBCL). This study presents the first case of BIA-FA-LBCL in Italy and one of the few assessed from a molecular standpoint so far. We identified two pathogenic mutations in DNMT3A and a variant of uncertain significance (VUS) in JAK2. These findings suggest that dysfunctional epigenetic mechanisms and constitutive activation of the JAK-STAT pathway may underpin BIA-FA-LBCL lymphomagenesis. Finally, we summarized all the previously reported cases in alignment with the updated WHO-HAEM5 classification, shedding further light on the nature of this new entity. This report highlights the rarity of BIA-FA-LBCL and underscores the importance of comprehensive capsule sampling and reporting to national databases for accurate characterization and management of these lymphomas. The study supports the classification of BIA-FA-LBCL within the spectrum of FA-LBCL, emphasizing the need for further research to elucidate its molecular underpinnings and improve clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
- Department of Oncology, Pisa University Hospital, Pisa, Italy.
- Anatomic Pathology Unit, Department of Medical Biotechnology, University of Siena, Siena, Italy.
- Breast Centre AOUP, University Hospital of Pisa, Pisa, Italy.
- Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Rome, Italy.
Zitieren
APA
Scatena, C., Naccarato, A. G., Vannucchi, M., Siciliano, M. C., Bonadio, A. G., Colizzi, L., Ghilli, M., Di Napoli, A., Fanelli, G. N., & Lazzi, S. (2024). Fibrin associated large B-cell lymphoma accidentally identified in a breast implant capsule: a molecular report of a rare entity. Pathologica. https://doi.org/10.32074/1591-951x-944
Vancouver
Scatena C, Naccarato AG, Vannucchi M, Siciliano MC, Bonadio AG, Colizzi L, et al. Fibrin associated large B-cell lymphoma accidentally identified in a breast implant capsule: a molecular report of a rare entity. Pathologica. 2024. doi:10.32074/1591-951x-944
BibTeX
@article{Scatena2024,
author = {Scatena, Cristian and Naccarato, Antonio Giuseppe and Vannucchi, Margherita and Siciliano, Maria Chiara and Bonadio, Angelo Giovanni and Colizzi, Livio and Ghilli, Matteo and Di Napoli, Arianna and Fanelli, Giuseppe Nicolò and Lazzi, Stefano},
title = {Fibrin associated large B-cell lymphoma accidentally identified in a breast implant capsule: a molecular report of a rare entity},
journal = {Pathologica},
year = {2024},
doi = {10.32074/1591-951x-944}
}
EUVIMED